We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
United States Lime & Minerals
USLM
$3.4B
| $412K | ﹤0.01% |
14,825
-2,050
| -12% | -$57.7K |
|
2652
CuriosityStream
CURI
$161M
| $410K | ﹤0.01% |
+30,058
| New | +$388K |
|
|
ZIXI
2653
DELISTED
Zix Corporation
ZIXI
| $410K | ﹤0.01% |
58,142
-7,996
| -12% | -$57.9K |
|
2654
Zevra Therapeutics
ZVRA
$679M
| $408K | ﹤0.01% |
+31,832
| New | +$342K |
|
|
AKTS
2655
DELISTED
Akoustis Technologies Inc
AKTS
| $408K | ﹤0.01% |
38,141
+5,917
| +18% | +$62.5K |
|
2656
CytomX Therapeutics
CTMX
$738M
| $406K | ﹤0.01% |
64,176
+3,190
| +5% | +$24.8K |
|
2657
Noodles & Co
NDLS
$108M
| $405K | ﹤0.01% |
4,057
-434
| -10% | -$40.4K |
|
2658
Park-Ohio Holdings
PKOH
$725M
| $405K | ﹤0.01% |
12,604
-2,127
| -14% | -$74.9K |
|
|
GNTY
2659
DELISTED
Guaranty Bancshares
GNTY
| $402K | ﹤0.01% |
11,789
-1,296
| -10% | -$49.3K |
|
2660
PAVmed
PAVM
$36.2M
| $402K | ﹤0.01% |
140
+72
| +106% | +$170K |
|
|
BVH
2661
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $402K | ﹤0.01% |
22,350
+1,993
| +10% | +$39.1K |
|
2662
SoundThinking
SSTI
$102M
| $400K | ﹤0.01% |
8,208
-3,524
| -30% | -$135K |
|
2663
Taysha Gene Therapies
TSHA
$1.85B
| $396K | ﹤0.01% |
+18,671
| New | +$430K |
|
|
SEI
2664
Solaris Energy Infrastructure
SEI
$3.56B
| $395K | ﹤0.01% |
40,555
-5,726
| -12% | -$60.6K |
|
2665
VirnetX Holding Corp
VHC
$62.8M
| $394K | ﹤0.01% |
4,609
+118
| +3% | +$11.1K |
|
2666
Citizens
CIA
$206M
| $393K | ﹤0.01% |
74,280
-7,206
| -9% | -$39.7K |
|
2667
NWPX Infrastructure Inc
NWPX
$1.15B
| $393K | ﹤0.01% |
13,909
-1,646
| -11% | -$52.3K |
|
2668
Radiant Logistics
RLGT
$397M
| $393K | ﹤0.01% |
56,715
-6,267
| -10% | -$45.4K |
|
2669
Teekay Tankers
TNK
$2.67B
| $392K | ﹤0.01% |
+27,177
| New | +$389K |
|
2670
Vital Farms
VITL
$542M
| $392K | ﹤0.01% |
19,631
-5,607
| -22% | -$124K |
|
2671
NVE Corp
NVEC
$620M
| $390K | ﹤0.01% |
5,273
-686
| -12% | -$48.9K |
|
2672
Franklin Covey
FC
$242M
| $389K | ﹤0.01% |
12,012
-1,738
| -13% | -$53.6K |
|
|
PCSB
2673
DELISTED
PCSB Financial Corporation
PCSB
| $389K | ﹤0.01% |
21,391
-3,662
| -15% | -$65.5K |
|
|
ARD
2674
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $389K | ﹤0.01% |
15,857
-925
| -6% | -$23.9K |
|
2675
Cullinan Oncology
CGEM
$1.13B
| $387K | ﹤0.01% |
15,027
+3,443
| +30% | +$106K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.